Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Question for the surgeons on the board who use davinci:
in your opinion, How is the image quality when using davinci?
I would imagine with news like this the PPS should rise unless its just fluff or the product isn't that good where discussion will lead to actual implementation
This is exactly what we thought we would get, a confirmation of the change in november and still on track fro Q1 milestone - no surprises and nothing new.
I would like to think that they will hit their Q1 milestone but mgmt's performance to date makes it a coin flip IMO. I guess the PPS will slow creep it's way north until March 31 when they either tell us they hit or miss the Q1 milestone. They hit it, PPS continues to climb....if they miss, well its easy to see what will happen then.
Based on the attendance at this conference, it looks like there is no potential partnership with a larger medical device company in play in the near future. It appears that they are either going to go it alone or flat out sell.
IMO, the managements strategy of continuing to be silent and milking it would lead me to believe that this will be a status quo report with nothing other than we continue to stay on track. Not bad news but a little worrisome b/c that is how the positioned it leading up to november's report. I agree that the Q1 Milestone HAS to be hit but don't anticipate them annoucning that until March 31 at midnight.
Sure, its quite simple, I would like to see Titan get bought - in order to get bought they need a buyer. JnJ is a company thrown around quite a bit on the board as a potential buyer but having more than one buyer helps drive the price up. Medtronic/Covidien could be another potential buyer but they weren't going to do anything until the merger of the 2 companies is finalized. If the Irish court approves it on Jan 29, the deal is done and Medtronic can begin to focus on moving forward and how they want to position themselves in the healthcare market.
IMO, now medtronic (and any other company interested in Robotic surgery, ISRG, Stryker, Olympus, etc, etc, etc) needs to identify how to capitalize on robust surgical robotics market growth that is currently taking place. If you saw ISRG's info yesterday, robotic procedures have increase 10% and expected to continue to grow at that pace - so more procedures are being done robotically and only ISRG is reaping the benefit.
Then if Titan can hit the Q1 milestone, get design freeze at that point it is seeing who will pay the most for Titan.
The first domino to fall into place for Titan
http://www.forbes.com/sites/greatspeculations/2015/01/13/medtronic-covidien-deal-may-close-by-jan-29/
Then the financials/MD&A around mid Feb,
Then Titan hitting their Q1 Milestone
Option 3 is the best one
it could also be viewed as a bad investment decision to sell the shares and buy warrants - depends on the lens you are looking thru
For the traders on the board, just a helpful tip from the medical industry, Titan is not going to market alone, they will either sell or partner, it is very clear by their actions (or inactions from a traders perspective). Just like traders can look at charts and technicals and see what direction a stock will go or what manipulation is taking place, individuals w/ experience in medical device/healthcare can see what path a company like Titan is going, IMO it is either selling or partnering.
For those that believe it will commercialize in 2017, why do you believe that? You obviously don't believe what they are telling you now yet you believe that they are going to commercialize in 2017 - sounds like picking and choosing the info you want.
Huge, Huge, Huge piece of information, GREAT FIND! Noticed it was filed on Oct 25, just before the public timeline change.
While some would argue that Titan should press release this to drive PPS up, I am not expecting it and that is why at times, I find this board so very valuable, when I can sort thru the Charlie Brown adult talk and get a piece of info like this, it helps give me reassurance in my investment
IMO, I am more convinced then before that Titan will be bought out sooner rather than later - it won't be the life changing $30, $50, $100/share but more in the range of $12-$18/share. The discussion within the healthcare giants is that they need to provide hospitals, etc with a robotic surgical platform in order to compete for the overall hospital business. They all are talking about getting into it now, 2 years is too late.
No way Titan comes to market - will be sold well before 2017
That is an excellent point about the timing of their own investment - if the stock was going to languish around this PPS for 12 months, why buy now? Invest that money elsewhere for a year, get 8-12% return and buy Titan later. I certainly don't buy that they were putting down $100k+ of there own money to appease the investors.
IMO of how she is going to help Titan, she hired Coleman Lannum
Reminder that Bertner is not a PR firm
I actually disagree about the position being irrelevant, it would be informative to know if they filled it b/c it address a need (getting financial information t/g and prepared,etc) or eliminating the position (too costly, not needed in the near future, etc).
One of the most anticipated reports that investors look to is the jobs report, why? b/c hiring (or lack of) provides some indications as to direction. What Titan has done with this position is just another piece of information that is part of the puzzle
Also, it looks like Titan no longer needs that Accounting Manager since it is not on their website anymore. Question would be, did they hire someone or did they decide not to pursue the position?
The covidien/Medtronic deal looks almost complete (pending Irish court approval - news today) and wouldn't be the least bit surprised to see them enter the mix for a surgical robotic platform (hopefully Titan but possibly someone else). They also were going to use $13.5B in cash on the deal but recently decided against that and are instead going to use the credit market (issuances of corp bonds as well) to finance the deal...which leaves them with that $13.5B in cash in hand.
On top of that, Coleman Lannum has a nice consultation position with Bertner and he has been right in the middle of one of the largest h/c mergers ever.
Someone on the board was talking to Randall and he mentioned that there would be some big, positive news towards the end of January. Maybe we assumed he was talking about Titan announcing some big positive news but maybe it's possible that he meant that the big Cov/Med deal would be done which would clear they way for Cov/Med to pursue a surgical robotics platform.
My opinion is that a buyout within 12-16 months will take place and if that is the direction Titan is planning why would they want the PPS to go up and have warrants excercised? It would seem to me that if you get a agreed upon purchase price from buyer (i.e. $4B) that they would prefer to have 100M shares outstanding ($40/share) rather than 145M outstanding (@ $27/share).
Question about Bertner and her firm, would an agreement in place prevent her from purchasing shares? Couldn't she be acquiring and holding Titan Stock just like us?
Yes, the answer to your question of whether JH is getting a great deal of pressure from Titan - my answer is no.
TimesYours get in here and control this thing. disclosure, I have not been invested in this for 3-5 years so for those who are, I can understand your frustration. I've been invested almost a year, so if in 1 year titan sold for $12.50/share - i'd be fine with that. Wouldn't be what I thought it could be but what I have learned investing in Titan would help me be a better investor in the "Next" company.
November was a big deflator for all of us but it happens. Focus on continuing to use this platform to help Titan go for a higher PPS when sold rather than bash their mgmt. There is one thing I can guarantee, no one on this board (as long as no one on this board works for Titan mgmt or SAB) knows what is going on behind the scenes. If anyone on this board can explain to me why Titan going for more indications does not make them more valuable w/o referencing PPS, than I'd like to hear it.
I'm curious why so many think that Titan will need 2 years (most of us don't even believe their timelines). Titan is setting itself up to be bought within 12-16 months. The BIG companies can not afford to wait too much longer to get into Robotic Surgery. There are several big companies that have to determine what type of robotic surgical platform they want to get into (TITAN, TRXC, et) and whether they want to develop their own platform or buy an up and coming platform. It's the only reason I own shares of Titan b/c I believe they will be bought. I don't want to see this go up to $12 to then fall all the way back to $2 b/c the want to artificially inflate PPS, I want them to get the indications for SPORT, go back to the big companies (including ISRG), show them what they have and let the bidding begin
Reminder that Bertner's firm is not a PR firm, her firm is designed to bring Titan and a Buyer together and that is not information that will ever leak out before the deal is done. IMO, Bertner will earn her money as Titan sells either at the end of 2015 or early 2016.
This is a great read from an interview that Ximedica's CEO gave on 12/11/14 that helps reaffirm my belief in the Titan/Ximedica parternship. Regardless of where you stand on Titan mgmt and how they deal with PR/Shareholders/PPS, it is nice to know that the Ximedica team is running with the true nuts and bolts aspect of making SPORT a commercially viable option. SPORT will be a huge, huge notch in the belt of XIMEDICA, hard to think they would completely lay an egg.
https://www.lifesciencealley.org/interview-with-randy-barko,-ceo-of-ximedica.html
Well done TimesYours you BSwD. Will you put him in timeout with this:
https://www.janilink.com/product_info.php?products_id=14772&source=googleps&gclid=CKCH56Sd1cICFajm7AodjSYA4
By the way, I looked at the TRXC Surgibot video and I thought that I heard "BOOM, CHICKA, BOOM, CHICKA, BOOM BOOM BOOM" as background music
Thanks, that helps. Any thoughts on if they are second to market being able to make money before SPORT arrives, esp in the ASC setting?
I have some interest in potentially making a small investment in TRXC, i believe there is some value being second to market (just on some customers strong to desire to buy anything but ISRG). A concern I have and if someone could share their analysis it would help but looking at the financials, TRXC seems to be burning through cash and will need to raise more money late 2015 if they don't make it to market by then. if anyone can share their thoughts on the financial and technicals, I would appreciate it.
Synecor doesn't appear to be an investment firm, more of an idea incubator, process enhancer (business generator)and a conduit b/t a company like TRXC and big institutional investors.
http://synecor.com/
It helps that they are located right down the street from Transenterix in NC and I believe they helped them with the Safestitch Merger. Also, they paid @ $8/share last December, I would imagine they would not have sold a single share since then considering all the $ they would have lost.
Also, just b/c they have financial partnerships or industrial partnerships with JnJ, Medtronic, GE, Boston Scientific doesn't mean those companies are invested in TRXC. I am a little surprised though that one of these companies hadn't made a play for TRXC if it is the next great robotic platform.
If Titan was planning to go this alone, they would have made a switch at CEO but I don't believe they have any intention of doing that. As someone pointed out JH is well connected and imo is in place to guide Titan thru the M/A process. That is what Bertner is doing (She/her company is not a web design company nor a PR company - check their website, no mention of PR or website design). Titan has $37M to put into more applications and design freeze, once those are accomplished then Titan hopefully goes to highest bidder. All the charts and technical analysis is helpful if trading on a day to day basis but Titan mgmt doesn't manage to the day to day news and certainly not interested in current PPS. They are focused on the sell, everything they don't do indicates to me that selling is their objective.
Another note, the transenterix news is very good for TITXF. Surgibot will have a place in robotics but SPORT will be that next step up. Once TRXC is approved then the FDA approval process will be that much easier for TITXF to navigate. While I am not happy with the delay, I can see where TItan mgmt saw that TRXC was close to being that second robot on the market and decided to let them wrestle with the FDA on approval. Seeing how the FDA handles TRXC will help Titan/Ximedica a great deal and probably shorten their FDA approval process b/c you will have "Similar" devices on the market rather than just one.
IMO, i don't see anything that Titan is doing that shows me they are coming to market and plan to sell SPORT themselves. They have strong patent protection (ask a patent attny friend to look at them), their Intellectual Property has value but since it was developed inhouse it does not show up on the balance sheets (my thoughts are the patents are worth minimum $3/Share).
Smart people (Fowler) don't just throw away $113K to make retail investors happy - no one on this board would give another person $100 to thow away. This management team's action is a selling mentality, they are lining up a buyer for Titan (meetings in NY, MedAssets Conf, no PR, etc). I do think it could be J&J but covidien or ISRG or anyone else will not let J&J have it for $14/share. Also, something has to give within the year, 3 years from now is too late and the robotic market will left Titan behind. My opinion, all signs point to them positioning to sell the company within 12 months. Take the $37M, invest it in developing other applications for SPORT and make it more attractive to a buyer.
They popped b/c they added a new board member, William Kelley MD. They big buy was a result of that news, telling us someone buys 1.23M shares is not news.
Titan mentioned that the "customer" wanted to see them get more indications for SPORT. It is possible that the "customer" could be a big company (insert company here: J&J, Covidien, ISRG etc) that expressed interest in acquiring Titan but couldn't justify their asking price b/c they had a product indicated for a market that did 450k procedures/year. Titan realizes that bringing SPORT out as is will be a tough sell either for a buyout or going it alone (who will want to buy a system that handles one procedure). They collect this info thru Bertner's discussions with big companies and the SAB's feedback regarding the market conditions of their facilities (and their colleagues). It's decided to pull back on commercializing as is and instead use the $37M in cash to enhance SPORT, increase its indications and go after a market of 4 million procedures. They will burn thru $28M by end of 2015 but it should be enough to get SPORT indicated for the other procedures and make them much more attractive for buyout. I've never believed they would or could go it alone (their management team doesn't strike me as the type) and I don't believe they will go it alone now. IMO, I believe this is all done to ultimately make SPORT a viable robotics platform to compete for the growing robotics market dollars and ultimately sell. 2015 is still a big year b/c if they don't hit their Q1 milestone and fall behind on gaining add'l indications, they burn thru cash and have to raise more money, potentially diluting the stock again. I'm long and believe in this product b/c the market is begging for another robotics platform (and not just one more player, probably 3-4 more in the next 2-3 years which the market can handle anyway) but I am with most of you about how the management has to do a better job of communicating with their stakeholders.
new corporate presentation on website
http://www.titanmedicalinc.com/wp-content/uploads/2014/11/Titan-Investor-Presentation-November-2014.pdf
http://www.onenewspage.us/n/Press+Releases/750q0kr0w/TransEnterix-Inc-to-present-at-the-Stifel-2014.htm
It would be curious to see what they present
This has been on Titan's website for awhile but a great reminder of why we are invested in Titan. I am looking forward to comparing the info released sometime in the next couple of weeks to this presentation to see progress.
http://www.titanmedicalinc.com/wp-content/uploads/2014/05/Investor-PresentationMay-21-2014.pdf
What an uninformed opinion.....oh no, is this thing on? Did I say that out loud?
just a thought, maybe there was some patent/IP issues with Transenterix systems that they just can't get around
Whatever the thoughts are about the Ximedica partnership with SLV or the delay of the financials today is that the value of Titan continues to increase. All it takes is one company to "overpay". Like I said earlier, maybe Ximedica picked up a nice chunk of that secondary offering - certainly would be attractive on the financials if you were considering taking a majority stake in XImedica.
As for Transenterix, they need to hire all those people b/c they don't know what they are doing. If I was a shareholder of Transenterix I wouldn't have a lot of faith when they give me a milestone of 510k approval and can't meet it.
IMO, when Titan releases their report: 1. Tissue validation completed and 2. Paperwork submitted for uplift to ny exchange
of course we are but we all are with our ideas, it's a reach to say Titan will RS or they will be bought before FDA or go it alone or to say it will be $3 by the end of the week in October.